Bullboard - Stock Discussion Forum Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,... see more

Add To Watchlist

GREY:ATBPF - Post Discussion

Antibe Therapeutics Inc(Pre-Merger) > A Little Disappointed

View:

Post by TheMadMonk on Feb 14, 2023 8:27pm

A Little Disappointed

The new anticipated start date for the Phase II bunionectomy trial is now calendar Q4 2023. On the plus side this gives me more time to continue to average down since there does not appear to be a catalyst for this stock until the fall. Who knows, maybe it can creep back below 50 cents with this new delay.

554

Comment

Comment by fox7mf on Feb 15, 2023 1:46pm

More delays. That's all this biotech is about now. Wallace retiring as well...jumping from a sinking ship? What say you Marky1 and Mugs? Does Ate ever bounce back?

Comment

Comment by Duster340 on Feb 15, 2023 11:49pm

i think you misread Dr.Wallace has not jumped ship yet, he still is with the company. Dr. John L. Wallace, has decided to retire from the Board of Directors. Dr. Wallace will remain a corporate Vice Chair, enabling the Company to continue to benefit from his wisdom and expertise.

Comment

Antibe Therapeutics Inc(Pre-Merger)